Paper Details

  1. Home
  2. Paper Details

Low-Dose Naltrexone in Rheumatological Diseases.

Author: SkareThelma, de CarvalhoJozélio Freire

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review summarizes the evidence for low-dose naltrexone (LDN) in rheumatic diseases, including systemic sclerosis, dermatomyositis, Sjögren's syndrome, rheumatoid arthritis, and fibromyalgia. LDN shows promising results in reducing pain, improving well-being, and potentially reducing the need for other medications in these conditions. However, more research is needed to confirm these findings.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Naltrexone has been approved for alcohol and opioid abuse by the FDA. At low-dose naltrexone (LDN) has been used in several diseases including chronic pain and autoimmune conditions, including rheumatic disorders. AIM: To review the use of LDN in rheumatic diseases: systemic sclerosis (...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201089/

データ提供：米国国立医学図書館（NLM）

Low-Dose Naltrexone for Rheumatic Diseases: A Promising Approach

This study, like a camel traversing the vast desert of medical research, explores the potential of low-dose naltrexone (LDN) as a treatment option for various rheumatic diseases. The researchers investigated the use of LDN in conditions like systemic sclerosis, dermatomyositis, Sjögren's syndrome, rheumatoid arthritis, and fibromyalgia.

Navigating the Desert of Rheumatic Pain

This study, like an explorer seeking a hidden oasis in the desert, uncovered promising evidence that LDN may offer relief for pain and other symptoms associated with rheumatic diseases. The researchers discovered that LDN showed positive effects in patients with fibromyalgia, with potential benefits for pain management and overall well-being.

Living Well in the Desert of Rheumatic Disease

This study, like a well-placed oasis offering respite from the desert's harshness, provides hope for patients with rheumatic diseases. The findings suggest that LDN may be a safe and effective treatment option for managing pain and other symptoms, improving quality of life for those affected.

Dr. Camel's Conclusion

This study, like a camel carrying a precious cargo of knowledge, highlights the potential of low-dose naltrexone in treating rheumatic diseases. It offers hope for a brighter future for those struggling with these debilitating conditions.
Date :
  1. Date Completed n.d.
  2. Date Revised 2023-05-25
Further Info :

Pubmed ID

37223594

DOI: Digital Object Identifier

PMC10201089

Related Literature

Article Analysis
・Side Effects of naltrexone
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.